JY: Writing review & editing
More serious risks include pancreatitis, gallbladder disease, acute kidney injury from dehydration, and hypoglycemia (when used with insulin or sulfonylureas)
Final Thoughts Retatrutide is a promising new weight loss medication that works by activating three hormone receptors: GLP-1, GIP, and glucagon
Retatrutide and newer agents Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously
How does Cagrilintide affect appetite compared to GLP-1 agonists
Is tirzepatide the same as mounjaro Tirzepatide and Belly Fat Is tirzepatide the same as ozempic Tirzepatide and hair loss Tirzepatide and birth control Tirzepatide and constipation Tirzepatide with b12 Is Tirzepatide Safe